US health insurance is an obstacle to disease-modifying treatments in MS.
Bourdette, Dennis
US health insurance is an obstacle to disease-modifying treatments in MS. [electronic resource] - Neurology 07 2016 - 346-7 p. digital
Publication Type: Editorial
1526-632X
10.1212/WNL.0000000000002904 doi
Humans
Immunomodulation
Insurance, Health--economics
Multiple Sclerosis, Relapsing-Remitting--drug therapy
United States
US health insurance is an obstacle to disease-modifying treatments in MS. [electronic resource] - Neurology 07 2016 - 346-7 p. digital
Publication Type: Editorial
1526-632X
10.1212/WNL.0000000000002904 doi
Humans
Immunomodulation
Insurance, Health--economics
Multiple Sclerosis, Relapsing-Remitting--drug therapy
United States